Glucose control and vascular complications in veterans with type 2 diabetes

Cited by (1,057)

Items 101–200 of 1,057

1. Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial.
   Del Prato, Stefano, Kahn, Steven E, Pavo, Imre, Weerakkody, Govinda J, Yang, Zhengyu, Doupis, John, Aizenberg, Diego, Wynne, Alan G, Riesmeyer, Jeffrey S, Heine, Robert J et al. · 2021 · The Lancet
2. Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes
   Hayward, Rodney A., Reaven, Peter D., Wiitala, Wyndy L., Bahn, Gideon D., Reda, Domenic J., Ge, Ling, McCarren, Madeline, Duckworth, William C., Emanuele, Nicholas V. · 2015 · New England Journal of Medicine
3. Three-year efficacy of complex insulin regimens in type 2 diabetes
   Holman, Rury R., Farmer, Andrew J., Davies, Melanie J., Levy, Jonathan C., Darbyshire, Julie L., Keenan, Joanne F., Paul, Sanjoy K. · 2009 · New England Journal of Medicine
4. Heart Failure in Type 2 Diabetes Mellitus
   Helena Kenny, E. Dale Abel · 2019 · Circulation Research
5. 6. Glycemic Targets: <i>Standards of Medical Care in Diabetes—2019</i>
   American Diabetes Association · 2019 · Diabetes Care
6. Type 2 diabetes mellitus and heart failure: a scientific statement from the American Heart Association and the Heart Failure Society of America: this statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update
   Dunlay, Shannon M., Givertz, Michael M., Aguilar, David, Allen, Larry A., Chan, Michael, Desai, Akshay S., Deswal, Anita, Dickson, Victoria Vaughan, Kosiborod, Mikhail N., Lekavich, Carolyn L. et al. · 2019 · Circulation
7. American Association of Clinical Endocrinologists and American College of Endocrinology – Clinical Practice Guidelines for Developing A Diabetes Mellitus Comprehensive Care Plan – 2015 — Executive Summary
   Yehuda Handelsman, Zachary T. Bloomgarden, George Grunberger, Guillermo E. Umpierrez, Robert S. Zimmerman, Timothy Silleck Bailey, Lawrence Blonde, George A. Bray, A. Jay Cohen, Samuel E. Dagogo-Jack et al. · 2015 · Endocrine Practice
8. Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes
   James J. Chamberlain, Andrew S. Rhinehart, Charles F. Shaefer, Annie Neuman · 2016 · Annals of Internal Medicine
9. Joint British Societies' consensus recommendations for the prevention of cardiovascular disease (JBS3)
   JBS3 Board · 2014 · Heart
10. Enhanced glucose control for preventing and treating diabetic neuropathy
    Brian Christopher Callaghan, Ann A. Little, Eva L. Feldman, Richard AC Hughes · 2012 · Cochrane Database of Systematic Reviews
11. Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations
    Bennett, Wendy L., Maruthur, Nisa M., Singh, Sonal, Segal, Jodi B., Wilson, Lisa M., Chatterjee, Ranee, Marinopoulos, Spyridon S., Puhan, Milo A., Ranasinghe, Padmini, Block, Lauren et al. · 2011 · Annals of Internal Medicine
12. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD)
    Lars Rydén, Peter J. Grant, Stefan D. Anker, Christian Berne, Francesco Cosentino, Nicolas Danchin, Christi Deaton, Javier Escaned, Hans‐Peter Hammes, Heikki Huikuri et al. · 2014 · Revista Española de Cardiología (English Edition)
13. Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm - 2020 executive summary
    Garber, Alan J., Handelsman, Yehuda, Grunberger, George, Einhorn, Daniel, Abrahamson, Martin J., Barzilay, Joshua I., Blonde, Lawrence, Bush, Michael A., DeFronzo, Ralph A., Garber, Jeffrey R. et al. · 2020 · Endocrine Practice
14. Advanced Glycation End Products (AGE) and Diabetes: Cause, Effect, or Both?
    Vlassara, Helen, Uribarri, Jaime · 2014 · Current Diabetes Reports
15. Diabetic nephropathy &amp;ndash; complications and treatment
    Lim, Andy · 2014 · International Journal of Nephrology and Renovascular Disease
16. Endothelial Cell Metabolism
    Guy Eelen, Pauline de Zeeuw, Lucas Treps, Ulrike Harjes, Brian W. Wong, Peter Carmeliet · 2017 · Physiological Reviews
17. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease
    Virani, Salim S., Newby, L. Kristin, Arnold, Suzanne V., Bittner, Vera, Brewer, LaPrincess C., Demeter, Susan Halli, Dixon, Dave L., Fearon, William F., Hess, Beverly, Johnson, Heather M. et al. · 2023 · Journal of the American College of Cardiology
18. Endothelial dysfunction in diabetes mellitus: Molecular mechanisms and clinical implications
    Corey E. Tabit, William B. Chung, Naomi M. Hamburg, Joseph A. Vita · 2010 · Reviews in Endocrine and Metabolic Disorders
19. Efficacy and safety of degludec versus glargine in type 2 diabetes.
    Marso, Steven P., McGuire, Darren K., Zinman, Bernard, Poulter, Neil R., Emerson, Scott S., Pieber, Thomas R., Pratley, Richard E., Haahr, Poul-Martin, Lange, Martin, Brown-Frandsen, Kirstine et al. · 2017 · New England Journal of Medicine
20. Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents
    Di Pino, Antonino, DeFronzo, Ralph A · 2019 · Endocrine Reviews
21. Impact of diabetes on cardiovascular disease: an update
    Matheus, Alessandra Saldanha de Mattos, Tannus, Lucianne Righeti Monteiro, Cobas, Roberta Arnoldi, Palma, Catia C. Sousa, Negrato, Carlos Antonio, Gomes, Marilia de Brito · 2013 · International Journal of Hypertension
22. American Association of Clinical Endocrinologists and American College of Endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015
    Handelsman, Yehuda, Bloomgarden, Zachary T., Grunberger, George, Umpierrez, Guillermo, Zimmerman, Robert S., Bailey, Timothy S., Blonde, Lawrence, Bray, George A., Cohen, A. Jay, Dagogo-Jack, Samuel et al. · 2015 · Endocrine Practice
23. Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention
    Dinesh Selvarajah, Debasish Kar, Kamlesh Khunti, Melanie Jane Davies, Adrian R. Scott, Jeremy Walker, Solomon Hailemariam Tesfaye · 2019 · The Lancet Diabetes & Endocrinology
24. Renal, metabolic and cardiovascular considerations of SGLT2 inhibition
    Ralph Anthony DeFronzo, Luke Norton, Muhammad A Abdul‐Ghani · 2016 · Nature Reviews Nephrology
25. Diabetic cardiomyopathy: Mechanisms and new treatment strategies targeting antioxidant signaling pathways
    Karina Huynh, Bianca C. Bernardo, Julie R. McMullen, Rebecca Helen Ritchie · 2014 · Pharmacology & Therapeutics
26. Microvascular Complications of Type 2 Diabetes Mellitus
    Charles J. Faselis, Alexandra Katsimardou, Konstantinos P. Imprialos, Pavlos Deligkaris, Manolis S. Kallistratos, Kiriakos Dimitriadis · 2019 · Current Vascular Pharmacology
27. Diabetes in sub-Saharan Africa: from clinical care to health policy
    Rifat Ali Atun, Justine Ina Davies, Edwin AM Gale, Till Bärnighausen, David Beran, André Pascal Kengne, Naomi Sharlene Levitt, Florence W Mangugu, Moffat Nyirenda, Graham David Ogle et al. · 2017 · The Lancet Diabetes & Endocrinology
28. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
    Frank L.J. Visseren, François Mach, Yvo Michiel Smulders, David Carballo, Konstantinos C. Koskinas, Maria Bäck, Athanase Bénétos, Alessandro Biffi, José-Manuel Boavida, Davide Capodanno et al. · 2021 · European Journal of Preventive Cardiology
29. Diabetes in Older Adults: A Consensus Report
    Sue Kirkman, M., Briscoe, Vanessa Jones, Clark, Nathaniel, Florez, Hermes, Haas, Linda B., Halter, Jeffrey B., Huang, Elbert S., Korytkowski, Mary T., Munshi, Medha N., Odegard, Peggy Soule et al. · 2012 · Journal of the American Geriatrics Society
30. Japanese clinical practice guideline for diabetes 2019
    Araki, Eiichi, Goto, Atsushi, Kondo, Tatsuya, Noda, Mitsuhiko, Noto, Hiroshi, Origasa, Hideki, Osawa, Haruhiko, Taguchi, Akihiko, Tanizawa, Yukio, Tobe, Kazuyuki et al. · 2020 · Diabetology International
31. Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management
    Amiel, Stephanie A, Aschner, Pablo, Childs, Belinda, Cryer, Philip E, de Galan, Bastiaan E, Frier, Brian M, Gonder-Frederick, Linda, Heller, Simon R, Jones, Timothy, Khunti, Kamlesh et al. · 2019 · The Lancet Diabetes &amp; Endocrinology
32. Effects of Cardiac Autonomic Dysfunction on Mortality Risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial
    Pop-Busui, Rodica, Evans, Gregory W., Gerstein, Hertzel C., Fonseca, Vivian, Fleg, Jerome L., Hoogwerf, Byron J., Genuth, Saul, Grimm, Richard H., Corson, Marshall A., Prineas, Ronald et al. · 2010 · Diabetes Care
33. Increased mortality of patients with diabetes reporting severe hypoglycemia
    McCoy, Rozalina G., Van Houten, Holly K., Ziegenfuss, Jeanette Y., Shah, Nilay D., Wermers, Robert A., Smith, Steven A. · 2012 · Diabetes Care
34. Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials
    Zoungas, Sophia, Arima, Hisatomi, Gerstein, Hertzel C, Holman, Rury R, Woodward, Mark, Reaven, Peter, Hayward, Rodney A, Craven, Timothy, Coleman, Ruth L, Chalmers, John · 2017 · The Lancet Diabetes &amp; Endocrinology
35. Receptor for AGE (RAGE): Signaling mechanisms in the pathogenesis of diabetes and its complications
    Ramasamy, Ravichandran, Yan, Shi Fang, Schmidt, Ann Marie · 2011 · Annals of the New York Academy of Sciences
36. Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association
    Biykem Bozkurt, David A. Aguilar, Anita M Deswal, Sandra Barker Dunbar, Gary S. Francis, Tamara B. Horwich, Mariell L Jessup, Mikhail Kosiborod, Allison M. Pritchett, Kumudha Ramasubbu et al. · 2016 · Circulation
37. Diabetic Microvascular Disease: An Endocrine Society Scientific Statement
    Eugene J. Barrett, Zhenqi Liu, Mogher Khamaisi, George Liang King, Ronald Klein, Ronald Klein, Timothy M. Hughes, Suzanne Craft, Barry I. Freedman, Donald W. Bowden et al. · 2017 · The Journal of Clinical Endocrinology & Metabolism
38. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for Developing a Diabetes Mellitus Comprehensive Care Plan
    Handelsman, Yehuda, Mechanick, Jeffrey I., Blonde, Lawrence, Grunberger, George, Bloomgarden, Zachary T., Bray, George A., Dagogo-Jack, Samuel, Davidson, Jaime A., Einhorn, Daniel, Ganda, Om et al. · 2011 · Endocrine Practice
39. American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update.
    Blonde, Lawrence, Umpierrez, Guillermo E., Reddy, S. Sethu, McGill, Janet B., Berga, Sarah L., Bush, Michael, Chandrasekaran, Suchitra, DeFronzo, Ralph A., Einhorn, Daniel, Galindo, Rodolfo J. et al. · 2022 · Endocrine Practice
40. Rates of Complications and Mortality in Older Patients With Diabetes Mellitus: The Diabetes and Aging Study
    Huang, Elbert S., Laiteerapong, Neda, Liu, Jennifer Y., John, Priya M., Moffet, Howard H., Karter, Andrew J. · 2014 · JAMA Internal Medicine
41. Insulin Resistance, Obesity and Lipotoxicity
    Dilek Yazıcı, Havva Sezer · 2017 · Advances in experimental medicine and biology
42. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2018 Executive Summary
    Alan J. Garber, Martin J. Abrahamson, Joshua I. Barzilay, Lawrence Blonde, Zachary T. Bloomgarden, Michael A. Bush, Samuel E. Dagogo-Jack, Ralph A. DeFronzo, DANIEL F. EINHORN, Vivian Andrew Fonseca et al. · 2018 · Endocrine Practice
43. Severe hypoglycaemia and cardiovascular disease: Systematic review and meta-analysis with bias analysis
    Goto, A., Arah, O. A., Goto, M., Terauchi, Y., Noda, M. · 2013 · BMJ
44. 6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes—2024
    Nuha A. ElSayed, Grazia Aleppo, Raveendhara R. Bannuru, Dennis Bruemmer, Billy S. Collins, Laya Ekhlaspour, Marisa E. Hilliard, Eric L. Johnson, Kamlesh Khunti, Ildiko Lingvay et al. · 2023 · Diabetes Care
45. Comorbidities of Diabetes and Hypertension: Mechanisms and Approach to Target Organ Protection
    Amanda N. Long, Samuel E. Dagogo-Jack · 2011 · Journal of Clinical Hypertension
46. Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy
    Sloan, Gordon, Selvarajah, Dinesh, Tesfaye, Solomon · 2021 · Nature Reviews Endocrinology
47. The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia
    Ralph Anthony DeFronzo, Jaime A. Davidson, Stefano Del Prato · 2011 · Diabetes Obesity and Metabolism
48. Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association
    Caroline S. Fox, Sherita Hill Golden, Cheryl A.M. Anderson, George A. Bray, Lora E. Burke, Ian H. de Boer, PRAKASH C. DEEDWANIA, Robert H. Eckel, Abby G. Ershow, JUDITH E. FRADKIN et al. · 2015 · Diabetes Care
49. 2016 European Guidelines on cardiovascular disease prevention in clinical practice
    Massimo Francesco Piepoli, Arno Wilhelmus Hoes, Stefan Agewall, Christian Albus, Carlos Brotons, Alberico Luigi Catapano, Marie Therese Cooney, Ugo Corrà, Bernard Cosyns, Christi Deaton et al. · 2016 · Atherosclerosis
50. GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes
    Nikolaus Marx, Mansoor Husain, Michael Lehrke, Subodh Verma, Naveed A. Sattar · 2022 · Circulation
51. 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes
    Das, Sandeep R., Everett, Brendan M., Birtcher, Kim K., Brown, Jenifer M., Januzzi, James L., Kalyani, Rita R., Kosiborod, Mikhail, Magwire, Melissa, Morris, Pamela B., Neumiller, Joshua J. et al. · 2020 · Journal of the American College of Cardiology
52. Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications
    Brian M. Frier · 2014 · Nature Reviews Endocrinology
53. New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism
    Stéphanie Eid, Kelli Margot Sas, Steven F. Abcouwer, Eva L. Feldman, Thomas W. Gardner, Subramaniam Pennathur, Patrice Elie Fort · 2019 · Diabetologia
54. Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials
    Jay S. Skyler, Richard M. Bergenstal, Robert O. Bonow, John B. Buse, PRAKASH C. DEEDWANIA, Edwin AM Gale, Barbara V. Howard, Marian Sue Kirkman, Mikhail Kosiborod, Peter D. Reaven et al. · 2009 · Journal of the American College of Cardiology
55. Advanced Glycation End Products (AGEs): Biochemistry, Signaling, Analytical Methods, and Epigenetic Effects
    Perrone, Anna, Giovino, Antonio, Benny, Jubina, Martinelli, Federico · 2020 · Oxidative Medicine and Cellular Longevity
56. Diabetes, hyperglycaemia, and acute ischaemic stroke
    Merel J.A. Luitse, Geert Jan Biessels, Guy E.H.M. Rutten, Laurens Jaap Kappelle · 2012 · The Lancet Neurology
57. Age-related changes in glucose metabolism, hyperglycemia, and cardiovascular risk
    Chia, Chee W., Egan, Josephine M., Ferrucci, Luigi · 2018 · Circulation Research
58. Metformin and inflammation: its potential Beyond glucose-lowering effect
    Saisho, Yoshifumi · 2015 · Endocrine, Metabolic &amp; Immune Disorders-Drug Targets
59. Adherence to diabetes medication: a systematic review
    Ines Krass, P. Schieback, Teerapon Dhippayom · 2014 · Diabetic Medicine
60. Hypoglycemia, Diabetes, and Cardiovascular Events
    Cyrus V Desouza, Geremia B. Bolli, Vivian Andrew Fonseca · 2010 · Diabetes Care
61. Current Epidemiology of Diabetic Retinopathy and Diabetic Macular Edema
    Jie Ding, Tien Yin Wong · 2012 · Current Diabetes Reports
62. Association Between Hypoglycemia and Dementia in a Biracial Cohort of Older Adults With Diabetes Mellitus
    Kristine S. Yaffe · 2013 · JAMA Internal Medicine
63. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II
    Beckman, Joshua A., Paneni, Francesco, Cosentino, Francesco, Creager, Mark A. · 2013 · European Heart Journal
64. Updated Cardiovascular Prevention Guideline of the Brazilian Society of Cardiology - 2019
    Dalton Bertolim Précoma, Gláucia Maria Moraes de Oliveira, Antônio Felipe Leite Simão, Óscar Pereira Dutra, Otávio Rizzi Coelho-Filho, Maria Cristina de Oliveira Izar, Rui Póvoa, Isabela de Carlos Back Giuliano, Aristóteles Comte de Alencar Filho, Carlos Alberto Machado et al. · 2019 · Arquivos Brasileiros de Cardiologia
65. Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm – 2017 executive summary
    Garber, Alan J., Abrahamson, Martin J., Barzilay, Joshua I., Blonde, Lawrence, Bloomgarden, Zachary T., Bush, Michael A., Dagogo-Jack, Samuel, DeFronzo, Ralph A., Einhorn, Daniel, Fonseca, Vivian A. et al. · 2017 · Endocrine Practice
66. Use of Metformin in the Setting of Mild-to-Moderate Renal Insufficiency
    Lipska, Kasia J., Bailey, Clifford J., Inzucchi, Silvio E. · 2011 · Diabetes Care
67. The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: Post hoc epidemiological analysis of the ACCORD study
    Miller, M. E, Bonds, D. E, Gerstein, H. C, Seaquist, E. R, Bergenstal, R. M, Calles-Escandon, J., Childress, R D., Craven, T. E, Cuddihy, R. M, Dailey, G. et al. · 2010 · BMJ
68. 2013 ESH/ESC Guidelines for the management of arterial hypertension
    Giuseppe Mancia, Robert H. Fagard, Krzysztof Narkiewicz, Josep Redón, Alberto Zanchetti, Michael Böhm, Thierry CM Christiaens, Renata Cífková, Guy De Backer, Anna F. Dominiczak et al. · 2013 · Blood Pressure
69. 6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes—2025
    American Diabetes Association Professional Practice Committee, ElSayed, Nuha A., McCoy, Rozalina G., Aleppo, Grazia, Balapattabi, Kirthikaa, Beverly, Elizabeth A., Briggs Early, Kathaleen, Bruemmer, Dennis, Echouffo-Tcheugui, Justin B., Ekhlaspour, Laya et al. · 2025 · Diabetes Care
70. Frequency of hypoglycemia and its significance in chronic kidney disease
    Moen, Maureen F., Zhan, Min, Hsu, Van Doren, Walker, Lori D., Einhorn, Lisa M., Seliger, Stephen L., Fink, Jeffrey C. · 2009 · Clinical Journal of the American Society of Nephrology
71. Diabetes Dyslipidemia
    Jonathan D. Schofield, Yifen Liu, Prasanna Rao‐Balakrishna, Rayaz Ahmed Malik, Handrean Soran · 2016 · Diabetes Therapy
72. Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society
    Seaquist, Elizabeth R., Anderson, John, Childs, Belinda, Cryer, Philip, Dagogo-Jack, Samuel, Fish, Lisa, Heller, Simon R., Rodriguez, Henry, Rosenzweig, James, Vigersky, Robert · 2013 · The Journal of Clinical Endocrinology &amp; Metabolism
73. Hemoglobin A 1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physicians
    Amir Qaseem, Timothy J Wilt, Devan L. Kansagara, Carrie Horwitch, Michael J. Barry, Mary Ann Forciea · 2018 · Annals of Internal Medicine
74. Risk of cardiac arrhythmias during hypoglycemia in patients with type 2 diabetes and cardiovascular risk
    Chow, Elaine, Bernjak, Alan, Williams, Scott, Fawdry, Robert A., Hibbert, Steve, Freeman, Jenny, Sheridan, Paul J., Heller, Simon R. · 2014 · Diabetes
75. Potential overtreatment of diabetes mellitus in older adults with tight glycemic control
    Lipska, Kasia J., Ross, Joseph S., Miao, Yinghui, Shah, Nilay D., Lee, Sei J., Steinman, Michael A. · 2015 · JAMA Internal Medicine
76. Diabetes structured self-management education programmes: a narrative review and current innovations
    Chatterjee, Sudesna, Davies, Melanie J, Heller, Simon, Speight, Jane, Snoek, Frank J, Khunti, Kamlesh · 2018 · The Lancet Diabetes &amp; Endocrinology
77. Efficacy and Safety of Antioxidant Treatment With α-Lipoic Acid Over 4 Years in Diabetic Polyneuropathy
    Dan Ziegler, Phillip A. Low, William J. Litchy, Andrew J.M. Boulton, Aaron I. Vinik, Roy L. Freeman, Р. Р. Самигуллин, Hans Tritschler, Ullrich Munzel, Joachim Maus et al. · 2011 · Diabetes Care
78. Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus
    Tahrani, Abd A., Barnett, Anthony H., Bailey, Clifford J. · 2016 · Nature Reviews Endocrinology
79. Probing SGLT2 as a therapeutic target for diabetes: basic physiology and consequences
    Gallo, Linda A, Wright, Ernest M, Vallon, Volker · 2015 · Diabetes and Vascular Disease Research
80. Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials
    Hemmingsen, B., Lund, S. S., Gluud, C., Vaag, A., Almdal, T., Hemmingsen, C., Wetterslev, J. · 2011 · BMJ
81. Glycemic Control and Risk of Infections Among People With Type 1 or Type 2 Diabetes in a Large Primary Care Cohort Study
    Julia Critchley, Iain M. Carey, Tess J Harris, Stephen DeWilde, Fay J. Hosking, Derek G. Cook · 2018 · Diabetes Care
82. National Trends in US Hospital Admissions for Hyperglycemia and Hypoglycemia Among Medicare Beneficiaries, 1999 to 2011
    Kasia J. Lipska, Joseph S. Ross, Yun Wang, Silvio E. Inzucchi, Karl E. Minges, Andrew John Karter, Elbert S. Huang, Mayur M. Desai, Thomas M. Gill, Harlan M. Krumholz · 2014 · JAMA Internal Medicine
83. Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association
    Fox, Caroline S., Golden, Sherita Hill, Anderson, Cheryl, Bray, George A., Burke, Lora E., de Boer, Ian H., Deedwania, Prakash, Eckel, Robert H., Ershow, Abby G., Fradkin, Judith et al. · 2015 · Circulation
84. Individualizing Glycemic Targets in Type 2 Diabetes Mellitus: Implications of Recent Clinical Trials
    Faramarz Ismail‐Beigi, Etie S. Moghissi, Margaret Tiktin, Irl B. Hirsch, Silvio E. Inzucchi, SAUL M. GENUTH · 2011 · Annals of Internal Medicine
85. PONTIAC (NT-proBNP Selected PreventiOn of cardiac eveNts in a populaTion of dIabetic patients without A history of Cardiac disease)
    Huelsmann, Martin, Neuhold, Stephanie, Resl, Michael, Strunk, Guido, Brath, Helmut, Francesconi, Claudia, Adlbrecht, Christopher, Prager, Rudolf, Luger, Anton, Pacher, Richard et al. · 2013 · Journal of the American College of Cardiology
86. Diabetes
    David M. Nathan · 2015 · JAMA
87. 13. Older Adults: <i>Standards of Medical Care in Diabetes—2022</i>
    American Diabetes Association Professional Practice Committee · 2022 · Diabetes Care
88. Hypoglycemia and cardiovascular risks
    Frier, Brian M., Schernthaner, Guntram, Heller, Simon R. · 2011 · Diabetes Care
89. Rationale and design of the Cardiovascular Inflammation Reduction Trial: A test of the inflammatory hypothesis of atherothrombosis
    Everett, Brendan M., Pradhan, Aruna D., Solomon, Daniel H., Paynter, Nina, MacFadyen, Jean, Zaharris, Elaine, Gupta, Milan, Clearfield, Michael, Libby, Peter, Hasan, Ahmed A.K. et al. · 2013 · American Heart Journal
90. Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: a cohort study
    Khunti, Kamlesh, Davies, Melanie, Majeed, Azeem, Thorsted, Brian Larsen, Wolden, Michael Lyng, Paul, Sanjoy K. · 2015 · Diabetes Care
91. American Association of Clinical Endocrinology consensus statement: comprehensive type 2 diabetes management algorithm—2023 update
    Samson, Susan L., Vellanki, Priyathama, Blonde, Lawrence, Christofides, Elena A., Galindo, Rodolfo J., Hirsch, Irl B., Isaacs, Scott D., Izuora, Kenneth E., Low Wang, Cecilia C., Twining, Christine L. et al. · 2023 · Endocrine Practice
92. Genetic and environmental factors associated with type 2 diabetes and diabetic vascular complications
    Mariana Murea, Lijun Ma, Barry I. Freedman · 2012 · The Review of Diabetic Studies
93. Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds
    for the ADVANCE Collaborative Group, Zoungas, S., Chalmers, J., Ninomiya, T., Li, Q., Cooper, M. E., Colagiuri, S., Fulcher, G., de Galan, B. E., Harrap, S. et al. · 2012 · Diabetologia
94. Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment
    Inês Falcão‐Pires, Adelino Ferreira Leite-Moreira · 2011 · Heart Failure Reviews
95. Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From aDiabetes CareEditors’ Expert Forum
    William T. Cefalu, Sanjay Kaul, Hertzel C. Gerstein, Rury R. Holman, Bernard Zinman, Jay S. Skyler, Jennifer B. Green, John B. Buse, Silvio E. Inzucchi, Lawrence A. Leiter et al. · 2017 · Diabetes Care
96. Renal reabsorption in 3D vascularized proximal tubule models
    Neil Y. C. Lin, Kimberly A. Homan, Sanlin S. Robinson, David B. Kolesky, Nathan Duarte, Annie Moisan, Jennifer A. Lewis · 2019 · Proceedings of the National Academy of Sciences
97. The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial
    van Bommel, Erik J.M., Muskiet, Marcel H.A., van Baar, Michaël J.B., Tonneijck, Lennart, Smits, Mark M., Emanuel, Anna L., Bozovic, Andrea, Danser, A.H. Jan, Geurts, Frank, Hoorn, Ewout J. et al. · 2020 · Kidney International
98. Canagliflozin slows progression of renal function decline independently of glycemic effects
    Heerspink, Hiddo J. L., Desai, Mehul, Jardine, Meg, Balis, Dainius, Meininger, Gary, Perkovic, Vlado · 2017 · Journal of the American Society of Nephrology
99. Cardiac autonomic neuropathy in patients with diabetes mellitus
    Gerasimos Dimitropoulos · 2014 · World Journal of Diabetes
100. Glycemic control and complications in type 2 diabetes mellitus
     Stolar, Mark · 2010 · The American Journal of Medicine